We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Werfen Unveils Next Generation Hemostasis Testing Systems

By LabMedica International staff writers
Posted on 30 Jul 2025

Werfen (Barcelona, Spain) is unveiling the next generation of market-leading ACL TOP hemostasis testing systems at the ADLM Annual Meeting 2025, reinforcing the company’s commitment to innovation in specialized diagnostics. More...

Werfen also has announced the expansion of its award-winning Gem Premier 7000 with iQM3 to Europe, following its strong clinical adoption in North America.

Werfen had recently announced the commercialization of ACL TOP Family 70 Series hemostasis testing systems in North America, following 510(k) clearance by the US Food and Drug Administration and licensure by Health Canada. Building upon the company’s established legacy of quality and innovation in hemostasis testing, the ACL TOP Family 70 series hemostasis testing systems optimize workflow with a powerful combination of quality and efficiency, and connectivity across an entire laboratory network. To streamline and optimize workflow, ACL TOP Family 70 Series systems offer centralized QC and automated performance verification management. When connected to HemoHub Intelligent Data Manager, synergistic integration allows uniform application of a laboratory’s Quality Management System across multiple instruments and sites, from one centralized location; transcription errors are eliminated, and report generation and storage are automated. Performance verification studies that previously involved several manual processes are reduced to two automated steps, saving significant staff time, improving quality, and reducing costs.

At ADLM 2025, Werfen has announced the expanded commercialization for the GEM Premier 7000 with iQM3, following its early success in North America. Building on strong clinical adoption and recognition in the United States, the system is now available in Europe. The GEM Premier 7000 is the first blood gas testing system to integrate hemolysis detection at the point of care, addressing the most common preanalytical error in blood gas testing. The system earned five prestigious industry awards, including the 2025 Edison Award and Premier Inc. Supplier Innovation Award, for its groundbreaking integration of hemolysis detection at the point of care. These honors highlight its innovation, quality, and positive impact on clinical workflows and patient care.

Related Links:
Werfen


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
Gold Member
Hematology Analyzer
Medonic M32B
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.